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Abstract	
In	 this	 study	 we	 examine	 the	 introduction	 of	 e-prescription	 in	 Norway	 and	 Greece	 as	 a	 process	 towards	
achieving	embeddedness	within	the	existing	information	systems´	landscape	of	healthcare.	This	requires	action	
taking	by	public	sector	actors	at	different	government	levels	and	also,	by	private	actors.	We	used	the	lens	of	
collective	 action	 for	 informing	 our	 investigation.	 Our	 analysis	 brings	 to	 focus	 the	 mechanisms	 of	 making	
initiatives	happen	when	participants	have	 the	 freedom	 to	make	 individual	decisions	on	 their	 contributions,	
structuring	their	work	in	the	best	way	they	consider	fit.	Specifically,	we	identified	how	the	solutions	evolved	
through	voluntary	cooperation,	strategic	interaction	and	selective	incentives.	Our	findings	contribute	to	to	the	
extant	 literature	 on	 national	 e-health	 solutions	 shifting	 the	 focus	 from	 the	 important	 technical	 issues	 of	
standardisation	and	integration	to	the	equally	important	issue	of	creating	the	conditions	for	collective	action.	
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1 INTRODUCTION	
E-prescription	solutions	capture	and	circulate	prescription	
information	between	prescribing	doctors,	pharmacies	and	
insurers	 that	handle	related	payments.	The	digitalisation	
of	 information	 flows	 eliminates	 practical	 legibility	 issues	
(frequently	 faced	when	using	handwritten	prescriptions)	
while	 significantly	 improving	 auditability.	 Overall,	 such	
solutions	contribute	to	cost	containment,	enhancement	of	
patient	safety,	visibility	over	doctors’	prescription	patterns	
and	 process	 quality	 assurance.	 In	 this	 respect,	 e-
prescription	 has	 a	 dual	 role:	 it	 is	 a	 tool	 introduced	 to	
everyday	work	to	improve	healthcare	delivery	and	also,	a	
mechanism	 for	 regulating,	 controlling	 and	 monitoring	 a	
large	 array	 of	 dispersed	 temporally	 and	 geographically	
professional	 tasks	 related	 to	 prescriptions’	 issuing,	
dispensing	 and	 reimbursing	 [1].	 Overall,	 putting	 e-
prescription	 in	 place	 entails	 working	 with	 multiple	 and	
diverse	 sociotechnical	 components,	 finding	 ways	 to	 link	
and	 organise	 them	 [2].	 During	 the	 past	 decade,	 most	
European	countries	had	to	address	increasing	healthcare	
costs	 and	 this	 fuelled	 the	 interest	 for	 e-prescription	
systems	across	Europe	[3].	According	to	the	World	Health	
Organization,	 pharmaceutical	 costs	 account	 for	 three	 of	
the	most	common	causes	of	health	systems’	inefficiency:	
reducing	 unnecessary	 expenditure	 on	 medicines,	 using	
them	more	appropriately,	and	 improving	quality	control,	
can	 contribute	 to	 significant	 health	 expenditure	
reductions	for	most	countries	[4].		
In	Norway,	the	government	initiated	e-prescription	back	in	
2003	 with	 the	 aim	 to	 solve	 problems	 in	 payments´	
settlement	for	pharmacists	and	bandagists	related	to	the	
circulation	 and	 processing	 of	 paper	 prescriptions	 [5].	 It	
was	important	for	the	authorities	to	monitor	and	control	
prescriptions	not	only	for	ensuring	healthcare	quality	but	
also	 for	 reasons	 of	 cost	 control.	 The	 introduction	 of	 e-
prescription	in	Norway	has	been	a	lengthy	and	challenging	
process	 entailing	 concerted	 action	 from	 multiple	 actors	
that	 developed	 extensions	 for	 a	 multitude	 of	 existing	
systems	 [6].	 Although	 it	 was	 initiated	 in	 2003,	 it	 took	
almost	a	decade	to	reach	full	deployment.	
The	 Norwegian	 e-prescription	 solution	 supports	 the	
registration,	circulation	and	storage	of	information	about	
patients	 (including	 their	 unique	 national	 identification	
number),	 prescribers,	 prescribed	 medicines	 and	
dispensing	pharmacies.	The	registration	of	information	is	
performed	via	the	Electronic	Patient	Record	(EPR)	systems	
and	 Pharmacy	 Management	 systems	 in	 doctors’	 offices	
and	pharmacies.	The	Patients	can	go	to	any	pharmacy	to	
fill	their	prescription	and	there	is	also	the	possibility	to	use	
e-pharmacies.	 Furthermore,	 the	 information	 on	 filled	
prescriptions	 is	 shared	with	NAV	 (the	Norwegian	Labour	
and	Welfare	Administration)	for	control	and	refunding.	E-
prescription	is	used	both	in	primary	care	and	in	hospitals.		
In	 Greece,	 the	 overall	 aim	 for	 e-prescription	 was	 to	
enhance	 control	 over	 pharmaceutical	 expenditure,	 to	
improve	 doctor-pharmacy	 collaboration	 and	 patient	
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safety	 and	 to	 capture	 data	 required	 to	 support	 policy	
development	 (Law	 3892/2010).	 The	 year	 when	 the	 e-
prescription	 law	passed	 (year	 2010)	 the	Greek	 economy	
was	 facing	 a	 severe	 public	 debt	 crisis	 which	 captured	
global	 attention.	 The	 strong	 financial	motivation	 behind	
the	 e-prescription	 initiative	 is	 demonstrated	 by	 its	
inclusion	 in	May’s	3rd	2010	“Memorandum	of	Economic	
and	 Financial	 Policies”	 between	 Greece	 and	 the	
International	 Monetary	 Fund	 and	 subsequently	 in	 the	
“Hellenic	National	Reform	Programme	2011-2014”	[7,	8].	
Differently	to	Norway,	the	deployment	of	e-prescription	in	
Greece	 was	 swift:	 development	 started	 in	 2010	 and	 by	
2013,	reached	almost	full	coverage	[9].			
The	 Greek	 e-prescription	 solution	 supports	 the	
registration	of	information	about	both	the	patient	and	the	
prescriber,	 the	 diagnosis,	 the	 medication	 specifications	
(type,	 quantity)	 and	directions	 for	 the	patient	 to	 follow.	
Prescribing	doctors	register	the	patient’s	name	and	social	
security	number,	the	diagnosis	encoded	according	to	ICD-
10,	 and	 the	 medications	 prescribed	 and	 then,	 print	 a	
summary	 page	which	 is	 handed	 to	 the	 patient.	 Patients	
can	 visit	 any	 pharmacy	 to	 fill	 prescriptions.	 Before	
delivering	medications,	pharmacists	 scan	 the	medication	
packages’	 barcodes	 which	 are	 then	 matched	 to	
prescription	 details.	 The	 information	 on	 filled	
prescriptions	is	sent	to	reimbursement	authorities.	Several	
rules	 related	 to	 reimbursement	 are	 inscribed	 in	 the	 e-
prescription	 solution	 (e.g.	 different	 percentages	 for	
patients’	share	of	costs).	The	rules	inscribed	are	not	only	
related	 to	 reimbursement.	 Therapeutic	 prescribing	
protocols	 for	 a	 series	 of	 conditions	 (i.e.	 diagnosis-based	
prescribing	 guidelines)	 have	 also	 been	 electronically	
implemented.	 The	protocols	 include	medication	of	 “first	
choice”,	secondary	medications,	alternative	therapies	and	
rare	 cases.	 E-prescription	 is	 used	 in	 primary	 care	 and	 in	
hospitals.	
Both	 e-prescription	 initiatives	 entailed	 introducing	 new	
technologies	not	as	standalone	objects,	but	as	elements	in	
larger	 infrastructural	 arrangements.	 Working	 within	
healthcare	is	especially	challenging	today	because	novelty	
has	to	link	to	historically	built	conventions	of	practice	and	
to	 technologically	 congested	 landscapes	 that	 are	 the	
outcome	 of	 intensive	 digitalization	 efforts	 undertaken	
during	 the	 last	 decades	 [10,	 11].	 This	 makes	 the	
introduction	of	new	electronic	systems	more	challenging	
than	it	was	a	couple	of	decades	ago	when	e-gov	initiatives	
were	 starting	 in	 other	 public	 sector	 domains	 (e.g.	 tax	
authorities).	Earlier	initiatives	encountered	less	populated	
and	 less	 diverse	 technological	 landscapes	 than	 the	 ones	
found	 today.	 Nowadays,	 national-level	 digital	 initiatives	
rely	 on	 synergizing	 with	 many	 actors	 to	 achieve	
embeddedness	[12,	13].	
We	examine	the	introduction	of	e-prescription	in	Norway	
and	Greece	as	a	process	towards	achieving	embeddedness	
within	 the	 existing	 information	 systems´	 landscape	 of	
healthcare.	 This	 requires	 action	 taking	 by	 public	 sector	
actors	at	different	government	levels	and	also,	by	private	
actors.	By	focusing	on	the	embeddedness	concern,	we	can	
use	 the	 lens	 of	 collective	 action	 [14]	 for	 informing	 our	
investigation.	The	literature	on	collective	action	grapples	
“with	the	age-old	problem	of	how	to	induce	collaborative	
problem	 solving	 and	 other	 forms	 of	 collective	 action	
among	 self-interested	 individuals,	 groups,	 or	
organizations,	assuming,	of	course,	that	they	share	at	least	
some	 common	 goals”	 (idem,	 p.	 60).	 This	 lens	 fits	 a	
situation	 where	 heterogeneous	 actors	 must	 develop	 or	
extend	 complementary	 resources	 through	 a	 dynamic	
process	 of	 collaboration.	 Heckathorn	 analysed	 collective	
action	based	on	three	underlying	mechanisms:	voluntary	
cooperation,	strategic	interaction,	and	selective	incentives	
[15].	As	collective	action	is	a	multifaceted	phenomenon	all	
three	 mechanisms	 are	 important.	 In	 voluntary	
cooperation,	 actors	 choose	 between	 two	 strategies	
(cooperate	 or	 not)	 forgoing	 any	 attempts	 to	 influence	
others.	In	strategic	interaction,	actors	make	their	choices	
conditional	 on	 others'	 choices	 according	 to	 principles	 of	
reciprocity.	 In	 the	 case	 of	 selective	 incentives,	 laws	 or	
social	norms	that	punish	defectors	or	reward	co-operators	
are	employed	to	facilitate	collective	action.		
The	remainder	of	the	paper	is	structured	as	follows:	first,	
we	present	the	method	used	for	collecting	and	analysing	
our	empirical	material,	then,	we	present	the	results	of	our	
investigation,	finally,	we	discuss	and	conclude	by	pointing	
to	the	contribution	of	this	research	and	further	research	
directions.		
2 METHOD	
The	research	reported	in	this	paper	is	based	on	a	multiple	
case	study	research	design	[16,	17].	Multiple	case	studies	
allow	 for	 comparison	 across	 cases,	 resulting	 to	 more	
robust	 conclusions	 [18].	 Being	 focused	 to	 a	 single	 case	
could	 result	 to	 naturalising	 many	 of	 their	 aspects	 or	
making	 them	 look	 too	 singular.	 This	 combined	 view	
allowed	us	 to	be	 sufficiently	attentive	 to	details	without	
losing	sight	of	the	overall	picture.		
Data	 were	 collected	 from	 on-line	 sources,	 documents,	
observations	and	interviews	with	key	actors	(Table	1).	As	a	
first	step	we	performed	‘‘within-case	analysis’’	which	led	
to	 the	 development	 of	 timelines	 for	 the	 two	 cases	 and	
preliminary	 narratives	 on	 their	 evolution.	 In	 the	 second	
step,	we	applied	a	cross-case	analysis	in	order	to	look	for	
patterns	across	the	cases.	At	this	step,	we	turned	to	the	
literature	 on	 collective	 action	 for	 dimensions	 around	
which	we	could	cluster	episodes	identified	during	the	first	
step	of	our	analysis.	Specifically,	we	looked	for	voluntary	
cooperation,	strategic	interaction,	and	selective	incentives	
following	Heckathorn	[15].	This	analysis	helped	us	explore	
how	e-prescription	solutions	were	made	possible	through	
collective	action.	
Case	 Data	source	 Description	
Norway	 Interviews	 Semi-structured	 interviews	
with	 professionals	 involved	
in	 the	 development	 of	 e-
prescription	 and	
professionals	 with	 domain	
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Case	 Data	source	 Description	
specific	 knowledge	 (21	 in	
total).	
Observations		 Attendance	 of	 project	
meetings	and	workshops	(50	
meetings,	10	workshops).	
Document	
analysis	
Norwegian	 Healthcare	
Strategic	Documents;	Policy,	
Regulation	 and	 Standards	
Documents;	 Project	
Documents.	
Greece	 Interviews	 Semi-structured	 interviews	
with	 professionals	 in	 the	
domain	(7	in	total).	
Observations	 On-site	 observations	 of	 e-
prescription	 use	 in	
pharmacies	 for	 three	 full	
days.	
Document	
analysis	
Legislation	 and	 guidelines,	
policy	 documents	 and	
strategic	 plans,	 press	
releases,	public	consultation	
documents,	 presentation	
documents,	 posts	 in	
professional	 electronic	
forums,	press	and	articles.			
Table	1	Data	Collection	
3 RESULTS	
3.1 Overview	of	the	two	cases	
E-prescription	was	introduced	in	both	Norway	and	Greece	
with	 the	 aim	 to	 be	 all-inclusive	 (covering	 primary	 and	
secondary	 care),	 for	 the	 whole	 country	 and	 allowing	
patients	 free	 choice	 of	 pharmacy	 for	 prescription	
dispensing.	 This	 makes	 the	 two	 cases	 comparable.	 The	
Greek	and	Norwegian	cases	covered	similar	functionalities	
and	 were	 pursued	 to	 a	 great	 extent	 through	 centrally	
decided	and	implemented	development	plans	(in	Norway	
led	 by	 the	 Directorate	 for	 Health,	 in	 Greece	 led	 by	 the	
Greek	 e-Government	 Centre	 for	 Social	 Security).	 These	
similarities	are	important	because,	within	Europe	there	is	
a	 great	 variety	 among	 e-prescription	 initiatives	 [3].	 For	
example,	 in	 England,	 a	 specialized	 e-prescription	 service	
only	 for	primary	care	was	 introduced.	 In	Spain	and	 Italy,	
initiatives	were	taken	at	the	region	level.	In	Sweden,	there	
was	 a	 decision	 to	 transmit	 electronic	 prescriptions	 to	
selected	pharmacies,	so	patients	could	not	walk-in	to	any	
pharmacy.		
Regarding	motivations,	 the	 cases	have	a	 lot	 in	 common.	
Firstly,	 they	 both	 aimed	 for	 cost	 containment,	 partly	
through	automating	parts	of	the	overall	process,	but	also	
through	enhanced	monitoring	of	drugs’	expenditures	and	
physicians’	 prescribing	 practices;	 also,	 they	 aimed	 for	
improving	 patient	 safety	 and	 for	 improving	 the	 overall	
quality	of	the	service	delivered	to	patients.	In	Greece,	the	
economic	situation	of	the	country	played	a	role	in	pushing	
the	project	forward.	The	project	was	run	during	a	difficult	
period	 for	 the	Greek	 economy,	 and	 this	 accelerated	 the	
introduction	 of	 new	 electronic	 tools	 to	 reform	 the	
healthcare	 sector.	 In	 Norway,	 the	 project	 was	 initially	
triggered	by	the	Office	of	the	Auditor	General’s	critique	of	
inadequate	monitoring	and	control	of	costs	related	to	drug	
use.	However,	 in	order	 to	ensure	physicians´	buy-in,	 the	
focus	 of	 the	 project	 changed	 early	 on	 from	monitoring,	
control,	and	cost	containment,	towards	improving	patient	
safety.	 Table	 2	 provides	 an	 overview	 of	 the	 temporal	
evolution	for	the	two	cases.	
Period	 Description	
Norwegian	e-prescription	
2003-2004	 Decision	to	initiate	e-Prescription	
2005-2006	 Starting	e-Prescription	program	
2007-2008	 Tender	
First	 Pilot	 (stopped	 after	 significant	
problems)	
2009-2012	 Re-planning		
Successful	pilot	and	rollout	
Prescribing	Module	developed	
2013-2016	 Extensions	 including:	 multidose	
dispensing,	 online-pharmacies	 and	 new	
projects	for	further	extensions	
Greek	e-prescription	
2010	 Decision	to	initiate	e-Prescription	
2011	 Pilot	and	rollout	
2013	 Coverage	98%		
2013-2015	 Extensions	 including:	 therapeutic	
protocols,	 caps	 for	 prescribing	 doctors,	
diagnostic	test	ordering		
Table	2	Temporal	evolution	of	the	e-prescription	cases	
Both	 e-prescription	 initiatives	 started	 with	 a	 focus	 on	
paper	prescriptions	and	aimed	at	first	to	digitize	the	paper-
based	 prescribing	 processes.	 They	 started	 with	 the	
(implicit)	 strategy	 of	 replicating	 existing	 paper-based	
practices	 and	 then,	 to	 a	 varying	 degree,	 enriching	 these	
with	 additional	 functions	 for	 detection	 of	 medication	
errors	 and	 decision	 support	 that	would	 improve	 patient	
safety.	However,	both	projects,	while	trying	to	stay	close	
to	the	existing	practices,	had	to	find	appropriate	strategies	
for	addressing	challenges.		
The	 Norwegian	 and	 Greek	 projects	 employed	 almost	
opposite	 strategies	 for	 dealing	 with	 the	 existing	
technological	 solutions.	 In	 the	 Norwegian	 case,	 the	
strategy	chosen	was	to	integrate	tightly	the	e-prescription	
modules	 implementing	 new	 functionality	within	 existing	
systems,	in	particular	Electronic	Patient	Record	(EPR)	and	
Pharmacy	 Management	 systems.	 Due	 to	 the	
comprehensive	 functionality	 specified,	 the	 project	
required	 extensive	 work	 from	 the	 vendors´	 side.	 The	
vendors	had	to	develop	new	and	quite	complex	software	
components,	modify	their	existing	solutions,	and	integrate	
them	to	the	national	e-prescription	solution.	This	resulted	
in	a	situation	where	the	overall	project	became	dependent	
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not	only	to	the	activities	of	the	vendors	directly	involved	
in	 the	 e-prescription	 project,	 but	 also	 to	 the	 overall	
situation	 within	 the	 vendor	 organizations.	 For	 instance,	
the	 project	 was	 slowed	 down	 by	 one	 vendor’s	 delayed	
development	of	a	new	product.	
Differently	 from	 the	 Norwegian	 project,	 the	 Greek	 one	
developed	first	a	simple	solution	based	on	easily	available	
and	 straightforward	 web	 technologies	 without	 pursuing	
integration	 with	 the	 Electronic	 Patient	 Record	 and	
Pharmacy	 Management	 systems	 that	 were	 already	 in	
place.	 These	 integrations	were	made	 possible	 at	 a	 later	
stage,	 after	 the	 initial	 launch	 of	 the	 simple	 standalone	
solution.	Due	to	economic	and	political	commitments,	the	
initial	solution	was	developed	within	a	very	tight	timeline	
and	 was	 launched	 within	 less	 than	 a	 year	 from	 the	
moment	that	development	started.	This	 is	 in	contrast	 to	
the	Norwegian	solution	 in	 terms	of	both	complexity	and	
time.	The	actual	“rollout”	of	the	solution	in	Norway	started	
eight	years	after	the	project	was	initiated.	
The	Greek	solution	was	first	extended	by	developing	and	
providing	Application	Programming	Interfaces	(APIs)	that	
the	 vendors	 of	 Pharmacy	 Management	 and	 Electronic	
Patient	 Record	 systems	 could	 use	 to	 integrate	 their	
solutions	 with	 the	 infrastructure.	 Then,	 various	 new	
functions	 were	 added	 such	 as	 the	 electronic	
implementation	of	therapeutic	prescribing	protocols,	and	
diagnostic	 tests´	 ordering.	 These	 extensions	 were	
implemented	 swiftly.	 This	 was	 possible	 because	 the	 e-
prescription	 solution	 was	 based	 on	 an	 expandable	
component-based	 architecture	 [19].	 In	 addition,	 the	
initiative	was	 run	 and	maintained	by	 a	 small	 centralized	
organization	that	had	flexibility	in	modifying	the	solution.	
Overall,	multiple	changes	have	taken	place	as	a	sequence	
of	small	steps.	
The	 Norwegian	 e-prescription	 solution	 is	 significantly	
more	 complex	 than	 the	 Greek	 one.	 Furthermore,	 the	
Norwegian	solution	was	expanded	beyond	the	traditional	
prescription	 areas.	 Specifically,	 it	 expanded	 into	
medication	 management	 of	 polypharmacy	 patients	 at	
home	and	in	nursing	homes	through	the	development	of	
new	functionalities	for	supporting	Multi-Dose	Dispensing.		
Also,	an	extension	was	developed	to	support	ordering	of	
prescription	 medications	 through	 online	 pharmacies.	
Recently,	 additional	 initiatives	 were	 launched.	 A	
comprehensive	 and	 updated	 overview	 of	 patient´s	
medications	at	a	given	time	is	being	developed.	This	new	
development	is	practically	signalling	the	phasing	out	of	the	
document	 logic	 of	 prescriptions	 (which	was	 the	 starting	
point	 in	 the	 e-prescription	 journey).	 A	 generic,	 semi-
independent	 component	 for	 electronic	 patient	 record	
systems	(named	FM	or	prescribing	module)	was	pivotal	for	
the	 successful	 deployment	 and	 evolution	 of	 e-
prescription.	FM	was	initially	used	to	secure	deployment	
of	 e-Prescription	 nationwide,	 making	 it	 much	 easier	 for	
EPR	vendors	to	add	e-prescribing	functionality	when	their	
in-house	 development	 efforts	 were	 not	 advanced	 (the	
estimated	cost	of	linking	an	existing	EPR	to	FM	is	1/100	of	
the	cost	required	for	developing	all	the	functionality	that	
the	FM	module	covers).	FM	was	built	having	in	mind	some	
of	 the	 EPR	 vendors	 that	 were	 lagging	 behind	 in	
development	 and	 also	 smaller	 vendors	 that	 develop	
systems	 for	 health	 practitioners	 with	 low	 prescribing	
volumes	(e.g.	dentists,	ophthalmologists)	but,	eventually	it	
was	 used	 also	 for	 adding	 e-prescribing	 functionality	 to	
hospital	 systems	and	 to	 the	 systems	used	 in	 community	
care	(Pleie-	og	omsorgstjenesten).	The	introduction	of	FM	
facilitated	 significantly	 the	 large	 scale	 deployment	 of	 e-
prescription	which	started	in	2011.	By	2013	e-prescription	
was	 in	 use	 by	 Doctors	 and	 Pharmacies	 throughout	 the	
country.	The	central	project	organization	used	this	module	
to	 develop	 the	 new	 functionalities	 in	 an	 experimental	
fashion	 being	 able	 to	 test	 prototypes	 and	 launch	 pilots	
without	involving	application	vendors.	
3.2 Collective	 action	 for	 the	 introduction	 of	 e-
prescription	
Starting	 from	 the	 three	 Hackathon´s	 fundamentals	 we	
look	 how	 the	 solutions	 evolved	 through	 voluntary	
cooperation,	strategic	interaction	and	selective	incentives	
in	the	two	cases.	
Voluntary	cooperation		
The	 Norwegian	 e-prescription	 is	 based	 on	 voluntary	
initiatives	(Norwegian:	dugnadstiltak).	Each	party	in	the	e-
prescription	 value	 chain	 is	 responsible	 not	 only	 for	 the	
system(s)	owned	and	controlled	but	also	for	the	overall	e-
prescription	function.	The	electronic	prescription	program	
is	anchored	on	national	policies	and	action	plans	but	relies	
on	the	contributions	of	multiple	parties	and	without	their	
participation	 it	 would	 have	 not	 been	 possible.	 Although	
the	 idea	 was	 to	 base	 everything	 on	 the	 voluntary	
cooperation	of	key	actors,	the	overall	architecture	of	the	
solution	 is	 such	 that	 there	 is	 full	 dependency	 on	
developments	 performed	 by	 each	 involved	 party.	 A	
Cooperation	 Agreement	 for	 developing	 e-prescription	
(Samhandlingsprotokoll)	 was	 signed	 between	 the	
Norwegian	Ministry	of	Health	and	all	 involved	parties	at	
the	 end	 of	 2006.	 Nevertheless,	 the	 agreement	 was	 not	
enough	for	securing	actual	participation.	One	of	the	initial	
steps	was	 the	 launching	 of	 a	 call	 for	 vendors	 to	 extend	
existing	EPR	systems	with	prescribing	functionality.	In	this	
initial	call,	only	one	EPR	vendor	responded.	This	company	
was	 developing	 at	 that	 time	 a	 new	 EPR	 product.	 An	
agreement	 was	 made	 and	 a	 pilot	 was	 planned	 for	 the	
beginning	of	2007.	This	plan	proved	to	be	overoptimistic	
and	 was	 later	 revised.	 Eventually,	 e-prescription	 was	
piloted	 in	May	2008	but	 it	was	not	 satisfactory	and	was	
eventually	stopped	mainly	due	to	the	overall	 immaturity	
of	 the	 new	 EPR	 product.	 This	 created	 the	 need	 for	 re-
planning	the	initiative.	
In	Greece,	the	initial	versions	of	e-prescription	in	the	2010-
2011	period	were	only	accessible	via	web	browsers.	There	
was	 no	 connectivity	 to	 the	 EPRs	 used	 by	 doctors	 or	 to	
pharmacy	 information	 systems.	 The	 idea	 was	 that	 EPR	
vendors	 and	 vendors	 of	 pharmacy	 information	 systems	
would	be	able	to	develop	at	their	own	pace	prescription	
modules	 for	 their	 systems	 at	 a	 second	 stage.	 This	 was	
made	 possible	 with	 the	 publishing	 of	 Application	
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Programming	 Interfaces	 (APIs)	 that	 allowed	 connectivity	
with	 doctors’	 and	 pharmacists’	 systems.	 The	 APIs	 for	
pharmacy	 systems	 were	 launched	 in	 2012	 and	 were	
subsequently	 used	 by	 multiple	 system	 providers	
connecting	 the	 majority	 of	 pharmacies	 (by	 the	 end	 of	
2012).	In	2015	the	APIs	for	doctors’	EPRs	were	launched.	
The	introduction	of	the	APIs	and	their	exploitation	by	third	
party	 system	 providers	 allowed	 e-prescription	 to	 get	
embedded	to	the	health	IT	landscape	gradually.		
In	Norway,	there	is	a	relatively	limited	number	of	vendors	
providing	EPRs	and	pharmacy	systems	(eight	different	EPR	
systems	from	six	vendors	used	by	hospitals	and	GPs,	also,	
at	that	time	all	pharmacies	were	using	the	same	solution	
which	was	developed	by	a	 software	 company	owned	by	
the	pharmacists’	 association;	 as	of	 2017	 there	are	 three	
pharmacy	systems).	Differently	to	this,	in	Greece	there	is	a	
multitude	of	EPR	and	pharmacy	system	providers.	 It	was	
virtually	 impossible	 to	 expect	 all	 parties	 to	 cooperate	
within	 the	 limited	 timeframe.	 Hence,	 a	 browser-based	
solution	was	 launched	 first	 and	 subsequently	 APIs	were	
published	 for	 voluntary	 use	 by	 system	 providers.	
Furthermore,	the	Greek	health	IT	landscape	was	not	only	
characterised	 by	 the	 diversity	 of	 pharmacy	 and	 doctor	
systems	 but	 also	 by	 the	 high	 fragmentation	 of	 social	
security.	There	were	many	different	social	security	funds	
in	place	with	their	own	registries	and	systems	in	place.	In	
January	2011,	the	service	was	officially	launched	in	4	social	
security	 funds.	 In	2012	 four	more	additional	 funds	were	
included.	 Each	 addition	 necessitated	 collaborating	 with	
the	different	funds	to	establish	information	exchange.		
Strategic	interaction	
When	 collective	 action	 is	 organized	 through	 strategic	
interaction,	some	actors	make	their	choices	conditional	on	
others'	 choices.	 This	 is	 different	 to	 pure	 voluntary	
cooperation	where	participants	take	action	irrespectively	
of	 the	 choices	 of	 others.	 In	 2010,	 in	 Norway	 the	
development	of	FM	started.	FM	was	conceptualized	as	a	
generic,	semi-independent	component	of	existing	EPRs;	all	
information	 exchanges	 with	 e-prescription	 actors	 would	
be	 taken	 care	 of	 by	 this	 module	 but	 it	 would	 not	 be	
functional	 in	 a	 standalone	basis	 (i.e.	 not	 possible	 to	 run	
without	an	EPR).		FM	could	be	used	in	the	case	of	further	
delays	 in	EPR	vendor	deliveries.	 FM	was	 initially	used	 to	
secure	deployment	of	e-prescription	nationwide,	making	
it	 much	 easier	 for	 EPR	 vendors	 to	 add	 e-prescribing	
functionality	 when	 their	 in-house	 development	 efforts	
were	not	advanced.	Actually	it	was	an	adjustment	to	the	
strategy	of	the	Health	Directorate	based	on	the	experience	
they	 had	with	 the	 vendors	 in	 the	 earlier	 stage.	 FM	was	
built	having	 in	mind	some	of	 the	EPR	vendors	 that	were	
lagging	behind	 in	development	and	also	smaller	vendors	
that	 develop	 systems	 for	 health	 practitioners	 with	 low	
prescribing	volumes	(e.g.	dentists,	ophthalmologists)	but,	
eventually	 it	 was	 used	 also	 for	 adding	 e-prescribing	
functionality	to	hospital	systems	and	to	the	systems	used	
in	community	care	(Pleie-	og	omsorgstjenesten).	The	FM	
module	was	offered	to	all	EPR	vendors	without	charge	for	
its	 use.	 For	 its	 implementation,	 vendors	 had	 to	 develop	
connections	 to	 their	 own	 systems	 and	 to	 handle	 user	
support.		
In	 the	 Greek	 case,	 the	 main	 challenges	 encountered	
related	 to	 ensuring	 information	 flows	 with	 the	 social	
security	 funds.	When	e-prescription	was	 first	 introduced	
the	funds	were	maintaining	multiple	electronic	registries	
for	 their	 members	 and	 several	 of	 those	 registries	 were	
incomplete.	 In	 an	 initiative	 parallel	 to	 e-prescription,	 a	
new	 system	 named	 ATLAS	 that	 includes	 a	 new	 national	
registry	for	all	healthcare	beneficiaries	was	developed	and	
launched	 by	 Greek	 e-Government	 Centre	 for	 Social	
Security	 in	 2014.	 ATLAS	 links	 multiple	 registries	 and	
supports	the	flow	and	storage	of	information	on	insurance	
status	and	social	insurance	contributions.	This	new	system	
was	linked	to	e-prescription	in	the	summer	of	2014.	
Selective	incentives	
Collective	action	among	large	groups	can	also	be	achieved	
with	the	use	of	selective	incentives,	such	as	laws	or	social	
norms,	 penalties	 for	 defectors	 or	 rewards	 for	 co-
operators.	 In	 both	 the	 Norwegian	 and	 the	 Greek	 case,	
special	 laws	were	 introduced	 for	electronic	prescription.	
Furthermore,	the	aim	was	to	achieve	universal	coverage,	
i.e.	 electronic	 prescription	 to	 become	 the	 norm.	 	 In	
Norway,	 vendors	 were	 reimbursed	 for	 their	 expenses	
while	in	Greece,	it	was	the	vendors	themselves	that	had	to	
cover	the	costs	(possibly	transferring	the	cost	to	the	end-
users	 or	 incurring	 it	 themselves	with	 the	 expectation	 to	
expand	their	user	base).	Furthermore,	 in	Norway,	at	 the	
pharmacy	 side,	 e-prescription	 was	 based	 on	 a	 newly	
developed	 pharmacy	 solution.	 As	 the	 new	 pharmacy	
system	 had	 to	 be	 deployed	 in	multiple	 pharmacies,	 the	
software	 company	 developed	 a	 middleware	 named	
migration-factory	 to	 speedily	 deploy	 the	 new	 system	
across	 Norway.	 Practically,	 the	 migration-factory	 was	 a	
demand	 from	 the	 Health	 Ministry	 as	 it	 was	 critical	 to	
ensure	 the	 possibility	 of	 dispensing	 electronic	
prescriptions	 from	 all	 pharmacies	 and	 not	 only	 from	
selected	few.	
4 DISCUSSION	
The	 development	 and	 implementation	 of	 e-prescription	
solutions	required	attention	to	the	distinct	capabilities	and	
interests	 of	 various	 actors	 while	 leveraging	 voluntary	
cooperation,	 strategic	 interaction,	 and	 selective	
incentives.	As	the	analysis	of	the	two	cases	shows,	there	
are	many	different	alternatives	for	the	development	and	
implementation	 of	 e-prescription	 and	 the	 configuration	
for	 each	 setting	 depends	 on	 the	 particularities	 of	 the	
actors,	their	capabilities	and	interests.	By	applying	the	lens	
of	collective	action	[14,	15],	we	provided	an	overview	of	
the	creation	of	 fully	 functional	 solutions	 that	depend	on	
contributions	from	multiple	actors.	
The	 findings	 from	 the	 study	 have	 implications	 for	 both	
research	 and	 practice.	 Regarding	 research,	 this	 study	
contributes	 to	 the	 extant	 literature	on	national	 e-health	
solutions	shifting	the	focus	from	the	 important	technical	
issues	 of	 standardisation	 and	 integration	 to	 the	 equally	
important	 issue	 of	 creating	 the	 conditions	 for	 collective	
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action	 taking.	 By	 analysing	 the	 development	 of	 e-
prescription	as	collective	action	we	illuminate	how	novel	
technical	 capabilities	 can	 become	 embedded	 to	 the	
technologically	 congested	 landscapes	 that	 characterize	
healthcare	 today.	 Regarding	 practice,	 findings	 from	 our	
study	can	inform	both	public	and	private	actors	 involved	
in	large	scale	e-health	initiatives.	Since	our	research	only	
investigated	 a	 specific	 type	 of	 e-health	 solutions	 (e-
prescription)	which	supports	both	healthcare	related	and	
administrative	 needs	 our	 findings	 might	 not	 be	
generalizable	 to	 all	 types	 of	 e-health	 solutions	 (for	
instance,	the	voluntary	cooperation	mechanism	might	not	
be	applicable	in	some	cases).	Therefore,	further	research	
in	large	scale	e-health	initiatives	with	the	lens	of	collective	
action	is	needed.	
5 CONCLUSION	
The	 e-prescription	 solutions	 are	 signalling	 a	 new	 era	 of	
digital	 initiatives	 shifting	 the	 focus	 from	 building	 novel	
functionalities	per-se	to	the	introduction	of	technological	
capabilities	that	incorporate	and	inter-operate	with	a	wide	
range	of	existing	 systems.	This	 kind	of	 situation	 calls	 for	
collective	action	among	diverse	public	and	private	actors	
that	need	to	interact	 in	complex	ways	to	implement	and	
upkeep	e-health	solutions.	Furthermore,	technologies	are	
changing	today	very	rapidly,	and	strategies	for	effectively	
managing	future	evolution	are	needed.		
In	this	study	we	examine	the	introduction	of	e-prescription	
in	 Norway	 and	 Greece	 as	 a	 process	 towards	 achieving	
embeddedness	 within	 the	 existing	 information	 systems´	
landscape	 of	 healthcare.	 This	 requires	 action	 taking	 by	
public	 sector	 actors	 at	 different	 government	 levels	 and	
also,	 by	 private	 actors.	 We	 used	 the	 lens	 of	 collective	
action	for	informing	our	investigation.	Our	analysis	brings	
to	 focus	 the	 mechanisms	 of	 making	 initiatives	 happen	
when	 participants	 have	 the	 freedom	 to	make	 individual	
decisions	on	their	contributions	structuring	their	work	 in	
the	best	way	they	consider	fit.		
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